Our medical team will assist you in choosing the option that aligns best with your individual needs, metabolism, and weight loss objectives
Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]
These effects occurred in 4070% of treated patients in clinical trials
early changes in waist circumference Months 4-6: Continued steady weight loss
At the same time, access remains uneven, and that has created a gap that counterfeit and compounded products have tried to fill
433 Remarkably, compared with untreated rats, treated rats exhibited a significant reduction in alcohol intake, which was reduced by half